XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 947 $ 947 $ 2,953 $ 2,939
Cost of products sold 452 439 1,389 1,329
Gross profit 495 508 1,564 1,610
Selling, general, and administrative expenses 372 401 1,204 1,187
Research and development expenses 46 41 141 131
Goodwill and intangible asset impairments 307 1,281 307 1,281
Restructuring and other costs 6 3 70 13
Operating loss (236) (1,218) (158) (1,002)
Other income and expenses:        
Interest expense, net 18 14 58 41
Other (income) expense, net (4) 9 16 20
Loss before income taxes (250) (1,241) (232) (1,063)
Provision (benefit) for income taxes 16 (164) (28) (128)
Net loss (266) (1,077) (204) (935)
Less: Net loss attributable to noncontrolling interest 0 0 (5) 0
Net loss attributable to Dentsply Sirona $ (266) $ (1,077) $ (199) $ (935)
Net loss per common share attributable to Dentsply Sirona:        
Basic (in dollars per share) $ (1.25) $ (5.01) $ (0.94) $ (4.34)
Diluted (in dollars per share) $ (1.25) $ (5.01) $ (0.94) $ (4.34)
Weighted average common shares outstanding:        
Basic (in shares) 211.8 214.9 212.7 215.6
Diluted (in shares) 211.8 214.9 212.7 215.6